Ratio Legis Kewenangan Diskresioner Kementerian Kesehatan Terkait Regulasi Komersialisasi Vaksin Gotong Royong Corona Virus Disease- 2019 (COVID-19)

Authors

  • Dewi Nawang Wulan Universitas Airlangga
  • Devi Ayunda Rahma Universitas Airlangga
  • Abdul Ghofur Universitas Hang Tuah
  • Benny Djudjuren Tarigan Universitas Hang Tuah

DOI:

https://doi.org/10.30649/ph.v22i1.102

Keywords:

Discretionary Authority, Commercialization, Gotong Royong vaccine, Business Entity/Legal Entity

Abstract

Regulation of the Minister of Health the Republic of Indonesia No. 18 of 2021 on Changes to the Regulation of the Minister of Health the Republic of Indonesia No. 10 of 2021 on the Implementation of Vaccination in the Framework of Prevention of Coronavirus Disease Pandemic 2019 (COVID-19) as a reference for the implementation of vaccination programs led to a research analysis on the ratio legis of the regulation of commercialization of gotong royong vaccine for legal entities or business entities. Meanwhile, reviewed based on presidential Regulation No. 14 of 2021 on Changes to Presidential Regulation No. 99 of 2020 on Vaccine Procurement and Vaccination Implementation in the framework of Countering the Corona Virus Disease Pandemic 2019 (COVID-19) does not regulate the commercialization of gotong royong vaccine for legal entities or business entities so that the expansion of authority or discretion is seen from the Regulation of the Minister of Health of the Republic of Indonesia Number 18 of 2021,  On the other hand, ministerial decisions that are beschikking / decree are reviewed based on the method of the legislative approach and the concept approach has exceeded the above regulations. The result of this study is that the ratio of legis to support the acceleration of pandemic response and the implementation of vaccination in the scope of force Majeure circumstances is required to assist legal entities, or business entities where it is regulated under the Regulation of the Minister of Health of the Republic of Indonesia interpreted in Presidential Regulation 99 of 2020 Article 17 paragraph (1) letter b included in other sources of legitimate vaccine procurement funding.

Downloads

Download data is not yet available.

References

Ferina, Belly Isnaeni, Eka Martina Wulansari. “Peran Kementerian Kesehatan Dalam Pengendalian Risiko Covid-19 Bagi Tenaga Kesehatan Berdasarkan Peraturan Menteri Kesehatan Nomor 66 Tahun 2016 Tentang Keselamatan Dan Kesehatan Kerja Rumah Sakit.” Jurnal Lex Specialis 1, no. 1 (2021): 1–9. http://openjournal.unpam.ac.id/index.php/jlsp/inde.

Hidayati, Taufika. “Corporate Social Responsibility (CSR) Sebagai Bentuk Tanggung Jawab Sosial Perusahaan Kepada Masyarakat.” Focus Hukum Upmi 1 (2020): 110.http://journal.upmi.ac.id/index.php/fhu/article/view/282.

Huda, Ni’matul. “Kedudukan Dan Materi Muatan Peraturan Menteri Dalam Perspektif Sistem Presidensial.” Jurnal Hukum Ius Quia Iustum 28, no. 3 (2021):

Rorong, Bherly Adhitya. “Penyalahgunaan Wewenang Oleh Pejabat Publik Dalam Melakukan Diskresi Dikaji Menurut UU No. 30 Tahun 2014.” Lex Administratum 8, no. 1 (2020):

Yuhdi, Mohammad. “Peranan Diskresi Dalam Penyelenggaran Pemerintahan.” Likhitaprajna Jurnal Ilmiah Fakultas Keguruan dan Ilmu pendidikan 15, no. 1 (2013):

Zaman, Muhamad Nafi Uz, Retno Saraswati, and Ratna Herawati. “Analisis Dan Evaluasi Kedudukan Peraturan Menteri Terhadap Peraturan Daerah Dalam Sistem Ketatanegaraan Indonesia.” Diponegoro Law Journal 9, no. 2 (2020):

Maria, Farida. Laporan Kompedium Bidang Hukum Perundang-Undangan. Jakarta, 2008.

RI, Kemenkes. “Data Vaksinasi COVID-19 (Update per 30 Desember 2021).” Https://Covid19.Go.Id/Berita/Data-Vaksinasi-Covid-19-Update-30-Desember-2021.

Undang-Undang Dasar Negara Republik Indonesia Tahun 1945.

Undang-Undang Nomor 39 Tahun 2008 tentang Kementerian negara (Lembaran Negara Republik Indonesia Nomor 166 Tahun 2008, Tambahan Lembaran Negara Nomor 4916).

Undang-Undang Nomor 15 Tahun 2019 tentang Pembentukan Peraturan Perundang-undangan (Lembaran Negara Republik Indonesia Nomor 183 Tahun 2019, Tambahan Lembaran Negara Nomor 6398).

Peraturan Presiden Nomor 18 Tahun 2021 tentang Kementerian Kesehatan (Lembaran Negara Republik Indonesia Nomor 83 Tahun 2021).

Peraturan Presiden Nomor 14 Tahun 2021 tentang Perubahan atas Peraturan Presiden Nomor 99 Tahun 2020 tentang Pengadaan Vaksin dan Pelaksanaan Vaksinasi dalam rangka Penanggulangan Pandemi Corona Virus Disease 2019 (COVID-19) (Lembaran Negara Republik Indonesia Tahun 2021 Nomor 66)

Peraturan Menteri Kesehatan Nomor 18 Tahun 2021 tentang Perubahan atas Peraturan Menteri Kesehatan Nomor 10 Tahun 2021 tentang Pelaksanaan Vaksinasi dalam rangka Penanggulangan Pandemi Corona Virus Disease 2019 (COVID 19) (Berita Negara Republik Indonesia Tahun 2021 Nomor 592)

Downloads

Published

2022-04-20

How to Cite

Wulan, D. N., Devi Ayunda Rahma, Abdul Ghofur, & Benny Djudjuren Tarigan. (2022). Ratio Legis Kewenangan Diskresioner Kementerian Kesehatan Terkait Regulasi Komersialisasi Vaksin Gotong Royong Corona Virus Disease- 2019 (COVID-19). Perspektif Hukum, 22(1), 53–79. https://doi.org/10.30649/ph.v22i1.102

Issue

VOLUME 22 ISSUE 1; MEI 2022

Section

Articles

Categories

License

Copyright (c) 2022 Perspektif Hukum

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The copyright of each article is retained by the respective author and publishing rights are granted to the Perspektif Hukum journal. This work is under Creative Commons Attribution-ShareAlike 4.0 International License. The journals' copyright policy has been revised in Volume 22 Issue 2; November 2022 and the same will be displayed in the full text PDF in the next issues.
 
Authors who publish with this journal agree to the following terms:
 
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal
 
Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
 
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).